guanfacinum 3 mg ut guanfacini hydrochloridum, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.04073661 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 39.80 mg, povidonum K 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, E 132, E 172 (flavum), pro compresso.
Packungsbestandteile
Delayed release tablets
Active Agent
Dose
Guanfacinum
3 mg
BAG: Active Agent
Dose
Guanfacinum
3 mg
Inactive agents
Dose
additional_information
(Flavum)
Acidi Methacrylici
Acidum Fumaricum
Cellulosum Microcristallinum
Crospovidonum
E 132
color.
E 172
color.
Ethylis Acrylatis Polymerisatum
Glyceroli Dibehenas
Hypromellosum
Lactose Monohydrate
39.8 mg
Natrii Laurilsulfas
Polysorbatum 80
Povidonum K
30
Pro Compresso
Silica Colloidalis Anhydrica
Source
Data was imported : 03.03.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
